Genmab — Maj 2020
-
Tror ikke vi allerede får dose-expansion (48mg) data på EHA. Updated dose-escalation data and RP2D will be presented. https://library.ehaweb.org/eha/2020/eha25th/293707/martin.hutchings.subcutaneous.epcoritamab.28gen3013.cd3xcd2029.in.patients.with.html?f=listing=0*browseby=8*sortby=1*search=epcoritamab
-
@GB jeg mener det er derfor de tester Amivantamab sammen med Lazertinib, som kan klare brain mets https://clinicaltrials.gov/ct2/show/NCT04077463
-
-
Tak peter12
-
Saad Usmani, MD, outlines the Phase 1 study investigating teclistamab in relapsed/refractory multiple myeloma https://obroncology.com/video-center/?category=all&subcategory=all&watch=NDg0NTEz
-
-
-
-
Usmani again https://www.youtube.com/watch?v=9MXX1-EP0i4
-
-
Det bemærkede jeg også i videoen.
-
Men ok. Det er jo Janssen som står for forsøget. https://www.ashclinicalnews.org/online-exclusives/early-data-teclistamab-shows-deep-responses-myeloma/
-
-
Teclistamab appears safe at all doses for relapsed/ refrektory Myeloma treatment. https://www.onclive.com/conference-coverage/asco-2020/teclistamab-appears-safe-at-all-doses-for-relapsed-refractory-myeloma-treatment?eKey=amFuYm9ydXAxOTc4QGdtYWlsLmNvbQ==
-
Dr.weitzman on reusing treatments in relapsed/refraktory Multiple Myeloma https://www.onclive.com/conference-coverage/asco-2020/teclistamab-appears-safe-at-all-doses-for-relapsed-refractory-myeloma-treatment?eKey=amFuYm9ydXAxOTc4QGdtYWlsLmNvbQ==
Jeg synes det var ok. Jansen køber ikke Genmab Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind